
ITF Therapeutics Opens New Headquarters to Support Rare Disease Community
News Summary ITF Therapeutics LLC has inaugurated its new U.S. headquarters in Concord, Massachusetts, dedicated to advancing treatment for Duchenne muscular dystrophy (DMD) and rare